Get more information
info@nadical.com
ABOUT US
We are a high-tech enterprise founded by the national talent team of Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences. We have an original bioluminescent protein probe technology, pioneered the world's leading bioluminescent detection methods, broke through the bottleneck of existing detection technology, and made large-scale, fast, portable blood assay possible. In the future, it can be widely used in medical care, food industry, agriculture, environmental protection and other fields.
We first launched rapid detection instrument and reagents for aging biomarker NAD+, empowering personalized aging interventions.
We conduct research on NAD+ regulation and aging medicine with our NAD+ cell lines, which can dynamically and in real-time depict the distribution and metabolic characteristics of NAD+ in subcellular structures, and assist partners in developing new anti-aging products and solutions.
Background
We are a national talent team of Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences;
We have the world's leading bioluminescent protein probe detection technology;
We make miniaturization of detection instruments possible;
We have achieved highly sensitive and rapid molecular detection that can be widely applied;
We empower scientific research and commercial services in fields such as healthcare and biopharmaceuticals;
Mission
Developing the bioluminescence detection industry to promote human health and longevity.
Vision
Everyone has fast testing and popularizes proactive health technologies.
Team
Partners
Shenzhen Institute of Advanced Technology(SIAT), Chinese Academy of Sciences
In February 2006, the Chinese Academy of Sciences, the Shenzhen Municipal Government and the Chinese University of Hong Kong jointly established the SIAT to carry out advanced technology research, and implement achievements transformation, project incubation and education. So far, more than 1800 enterprises have been incubated, including more than 60 listed companies.
Collaboration: Key technology research and development of bioluminescent protein probes.
Sino-European Center of Biomedicine and Health(SEC)
Founded in March 2023, SEC, jointly built by Luohu District Government and SIAT, is a biomedical science and innovation industry platform for Luohu District to deeply implement Shenzhen's "20+8" health industry cluster strategy.
Collaboration: Incubation of Aging Intervention Technology Industry
The Third Affiliated Hospital of Sun Yat-sen University
The Third Affiliated Hospital of Sun Yat-sen University was founded in 1971 and is a comprehensive tertiary Grade A hospital directly managed by the National Health Commission. In recent years, it has won a series of honorary titles, such as the National Baby Friendly Hospital and the National Advanced Collective in Fighting COVID-19 etc.
Collaboration: Clinical application research of aging biomarker detection technology
Chinese PLA General Hospital (Beijing 301 Hospital)
301 Hospital is a large-scale modern comprehensive hospital that integrates medical treatment, healthcare, teaching, scientific research, prevention, rehabilitation, nuclear, biochemical protection, and medical rescue, striving to build a world-class hospital.
Collaboration: Clinical application research of aging biomarker detection technology
Global Customers
Solutions
NAD+ is a key target for anti-aging research. We provide sample testing services for partners to conduct real-world NAD+ metabolic regulation research, and provide data support for related academic research, product development, and personalized health management services.

NAD+ sample testing service
We provide sample testing services for NAD+metabolic regulation research, supporting related academic research, product development, and personalized health management services.
NAD+ regulatory solution
We evaluate and optimize the performance of existing solutions in NAD+ metabolic regulation for our partners, helping to achieve the optimal solution for personalized anti-aging health management.
Optimizing product formula design through live cell NAD+ detection
We provide subcellular structural NAD+ distribution and metabolism research using our unique NAD+ protein probe cell lines, providing evaluation methods and decision-making basis for optimizing the design of NAD+ booster supplements.
Products
NAD+ Analyzer
The world's first NAD+ analyzer uses Nadical® bioluminescent protein probes to complete the detection of NAD+ concentration in biological samples within minutes, helping research institutions and health management institutions to establish their own on-site detection capabilities. NAD+ (nicotinamide adenine dinucleotide, referred to as coenzyme I) is an important redox coenzyme that is widely present in all biological cells and directly participates in hundreds of important biochemical react
NAD+ Detection Reagents
Nadical Bioluminescent Protein Probe Kit can be directly applied to dual-wavelength microplate readers, enabling anti-aging research and service agencies to quickly detect NAD+, making large-scale anti-aging research possible. NAD+ (nicotinamide adenine dinucleotide, referred to as coenzyme I) is an important redox coenzyme that is widely present in all biological cells and directly participates in hundreds of important biochemical reactions, including energy metabolism, gene repair, anti-oxidat
NAD+ Cell Lines
We provide a variety of cells containing NAD+ probes, so that research institutions can conduct their own research on NAD+ distribution and metabolism in subcellular structures, find new intervention pathways and targets, and screen new drug molecules with high throughput. NAD+ (nicotinamide adenine dinucleotide, referred to as coenzyme I) is an important redox coenzyme that is widely present in all biological cells and directly participates in hundreds of important biochemical reactions, includ